Protein-based nanotechnology: Antibody conjugated with photosensitizer in targeted anticancer photoimmunotherapy

  • Authors:
    • Jerzy Jankun
  • View Affiliations

  • Published online on: July 1, 2011     https://doi.org/10.3892/ijo.2011.1110
  • Pages: 949-953
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Photodynamic therapy (PDT) is a minimally invasive cancer therapy that depends on the buildup of a photosensitizing drug within targeted tissue. The photosensitizer is subsequently activated by light of a specific wavelength, resulting in destruction of the targeted tissue by free radicals or singlet oxygen. Successful treatment requires delivery of critical amounts of drug into the cancerous tissue. This frequently demands high doses of the drug in the circulatory system that could lead to side effects in normal daylight due to accumulation of photodrug in normal tissue. To reduce drug load we explored the possibility of targeting cancer with antibody conjugated with photosensitizer. As a model we used LnCAP human prostate cancer cells targeted by antibody (against prostate-specific membrane antigen) which was conjugated with hematoporphyrin (HP). Our results show clearly that mAb/HP conjugates can deliver HP to the tumor cells which would result in considerably less HP in the circulation and, therefore, lower the delivery of HP to normal tissue, resulting in fewer side effects.

Related Articles

Journal Cover

October 2011
Volume 39 Issue 4

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Jankun J: Protein-based nanotechnology: Antibody conjugated with photosensitizer in targeted anticancer photoimmunotherapy. Int J Oncol 39: 949-953, 2011
APA
Jankun, J. (2011). Protein-based nanotechnology: Antibody conjugated with photosensitizer in targeted anticancer photoimmunotherapy. International Journal of Oncology, 39, 949-953. https://doi.org/10.3892/ijo.2011.1110
MLA
Jankun, J."Protein-based nanotechnology: Antibody conjugated with photosensitizer in targeted anticancer photoimmunotherapy". International Journal of Oncology 39.4 (2011): 949-953.
Chicago
Jankun, J."Protein-based nanotechnology: Antibody conjugated with photosensitizer in targeted anticancer photoimmunotherapy". International Journal of Oncology 39, no. 4 (2011): 949-953. https://doi.org/10.3892/ijo.2011.1110